Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
about
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.Health disparities among workers and nonworkers with functional limitations: implications for improving employment in the United StatesProblems associated with long-term treatment with selective serotonin reuptake inhibitors.Serotonergic antidepressants and perioperative bleeding risk: a systematic review.Vortioxetine : a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder.Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.Risk of Bleeding in Patients on Full-Dose Enoxaparin With Venous Thromboembolism and Selective Serotonin Reuptake Inhibitors.5-Hydroxytryptamine Changes under Different Pretreatments on Rat Models of Myocardial Infarction and/or Depression.Health risk profile for older adults with blindness: an application of the International Classification of Functioning, Disability, and Health framework.Multiple health disparities among minority adults with mobility limitations: san application of the ICF framework and codes.Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR.
P2860
Q36445716-77992D52-5550-496D-9408-166141D0EA43Q37045448-449B7EC0-C6CA-41BA-904A-54E079BE6C37Q37219382-F7A7E973-8F12-4CF4-82F4-D98254CE5147Q38203347-C444CE62-1959-4C08-8B0B-86A8346C1DB3Q38506798-5A07406F-5B87-4E67-A74E-8802686873AAQ39002032-370B6028-5CDC-43EF-9D8B-E170D96538D2Q40480045-7FB8CDA4-6A79-4B87-8421-1E5D415C770AQ41097776-44CCAD10-F285-407A-9EB5-780C0771CEADQ42797051-C003AF67-A2B0-4055-AE9C-14AE6100E09BQ44471965-B74D0B48-3F67-49F7-825E-6460ED8CFB5AQ47864318-24A6449F-EA96-49EA-8AA5-9D8178C0BAE2
P2860
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@ast
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@en
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@nl
type
label
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@ast
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@en
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@nl
prefLabel
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@ast
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@en
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@nl
P2093
P2860
P1476
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2006.01720.X
P407
P577
2007-03-01T00:00:00Z